Literature DB >> 23174191

Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far?

Massimo Breccia1, Maria Teresa Voso, Giuliana Alimena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23174191     DOI： 10.1016/j.leukres.2012.10.023

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

1.  Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy.

Authors:  Pasquale Niscola; Andrea Tendas; Laura Scaramucci; Marco Giovannini; Daniela Piccioni; Paolo de Fabritiis
Journal:  Blood Res       Date:  2014-03-24

2.  Azacitidine in chronic myelomonocytic leukemia: an effective and manageable approach.

Authors:  Andrea Tendas; Luca Cupelli; Agostina Siniscalchi; Laura Scaramucci; Marco Giovannini; Teresa Dentamaro; Alessio Perrotti; Tommaso Caravita; Paolo de Fabritiis; Pasquale Niscola
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-02-16       Impact factor: 2.576

3.  Fighting back against chronic myelomonocytic leukemia.

Authors:  Deog-Yeon Jo
Journal:  Blood Res       Date:  2013-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.